A bench of Chief Justice Manjula Chellur and Justice N M Jamdar also directed the Centre to inform the court of the steps taken to stop the widespread online advertisements for sale of drugs without prescription.
The directions came while the bench was hearing a Public Interest Litigation (PIL) seeking that the government tackle illegal sale of 'Schedule H' or prescription medicines online.
Also Read
As per the plea, the provisions of Drugs and Cosmetics Act 1940, and Drugs and Cosmetics Rules 1945, prohibit online sale of such medicines that mandatorily require a doctor's prescription.
Such drugs include anti-pregnancy pills, sleeping tablets and abortion pills.
The Centre told the court that in order to regulate the online sale of such medicines, it had already proposed to set up an e-portal where all manufacturers, distributors, and retailers who wish to sell medicines online, will have to mandatorily register themselves.
It said that action had been taken against several portals in this regard.
The bench noted that several drug manufacturers and sellers continued to advertise the sale of such drugs online.
It took note of a bunch of prints of such advertisements submitted by the petitioner.
"This is a serious issue. So many young students fall prey to serious and, in some cases, irreparable health hazards because of taking medicines without a doctor's prescription. What have you done to stop this?" the bench said.
Considering the seriousness of the issue, the bench also appointed advocate Zal Andhyarujina as the amicus curiae, or the lawyer to assist the court while hearing the matter, and to suggest remedial measures.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)